The largest database of trusted experimental protocols

Jnk inhibitor 5

Manufactured by Cayman Chemical
Sourced in United States

JNK inhibitor V is a small molecule compound that selectively inhibits the c-Jun N-terminal kinase (JNK) signaling pathway. JNK inhibitors are a class of pharmacological agents used in research to study the role of the JNK pathway in cellular processes.

Automatically generated - may contain errors

3 protocols using jnk inhibitor 5

1

Inhibition of MAP1B Phosphorylation in Cortical Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cerebral cortex neurons of E15 mice were cultured, as described previously [4 (link), 6 (link), 21 (link)]. For the inhibition assay of MAP 1B phosphorylation, 4 days in vitro (DIV) cortical neurons were treated for 24 h with culture medium containing DMSO as a control, one of three JNK1 inhibitors [SP600125, JNK Inhibitor V, and JNK Inhibitor XVI (Cayman Chemical, USA)], or one of three GSK3β inhibitors [IM-12, TDZD-8 (Cayman Chemical, USA), and LiCl (99.5% purity, Wako, Osaka, Japan)]. Cells exposed to each inhibitor were lysed in 1 × SDS-PAGE sample buffer and processed for western blotting analysis.
+ Open protocol
+ Expand
2

Elucidating Signaling Pathways Modulating NP Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antagonists or inhibitors involved in the NF-κB and MAPK signal pathways were introduced to verify the action of NP. The endocytosis inhibitors Pitstop2 (12.5 μM, Sigma) and Dynasore hydrate (12.5 μM, Sigma), the TLR4 antagonist LPS-RS (10 μg/ml; InvivoGen, San Diego, CA), the TLR1/TLR2 antagonist CU-CPT22 (20 μM, Millipore, Burlington, MA), the IL-1R antagonist (20 μM; Cayman Chemical Company), IKK-16 (20 μM; Cayman Chemical Company), the JNK inhibitor V (20 μM; Cayman Chemical Company), the ERK1/2 inhibitor U0126 (20 μM, Cell Signal Technology), and the p38 inhibitor SB203580 (20 μM; Enzo Life Sciences, Farmingdale, NY) were added to HLMEC cultures 1 h before NP exposure. The whole-cell lysates were harvested 8 h after NP stimulation and analyzed by Western blotting.
+ Open protocol
+ Expand
3

Deciphering NF-κB and MAPK Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antagonists or inhibitors involved in NF-κB and MAPK signal pathway were introduced to verify the action of NP. The endocytosis inhibitors Pitstop 2 (12.5 μM, Sigma) and Dynasore hydrate (12.5 μM, Sigma), the TLR4 antagonist LPS-RS (10 μg/mL, InVivoGen, San Diego, CA), the TLR1/TLR2 antagonist CU-CPT22 (20 μM, Millipore, Burlington, MA), the IL-1R antagonist (20 μM, Cayman Chemical Company), IKK-16 (20 μM, Cayman Chemical Company), the JNK inhibitor V (20 μM, Cayman Chemical Company), the ERK1/2 inhibitor U0126 (20 μM, Cell Signal Technology), and the p38 inhibitor SB203580 (20 μM, Enzo Life Sciences, Farmingdale, NY) were added into HLMEC cultures 1 h before NP exposure. The whole cell lysates were harvested 8 h after NP stimulation and analyzed by western blot.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!